SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals.


Journal

Journal of infection and public health
ISSN: 1876-035X
Titre abrégé: J Infect Public Health
Pays: England
ID NLM: 101487384

Informations de publication

Date de publication:
08 2021
Historique:
received: 24 05 2021
revised: 03 07 2021
accepted: 07 07 2021
pubmed: 23 7 2021
medline: 4 8 2021
entrez: 22 7 2021
Statut: ppublish

Résumé

Great expectations are placed in vaccines against COVID-19 to control the pandemic. We reviewed the antibody titres in a cohort of healthcare workers (HCWs) vaccinated with BNT162b2 to assess the influence of a previous infection on them. We stratified the results according to the individual history of nasopharyngeal swab (NPS) and symptoms. Among 3475 HCWs the highest titres were recorded among those infected more than 6 months before vaccination, independently of symptoms, followed by those infected less than 6 months before vaccination, especially in those with symptoms, and by uninfected HCWs. Vaccination with BNT162b2 can boost immunity acquired through infection, particularly in those infected more than 6 months before vaccination.

Identifiants

pubmed: 34293641
pii: S1876-0341(21)00192-1
doi: 10.1016/j.jiph.2021.07.005
pmc: PMC8285930
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0
BNT162 Vaccine N38TVC63NU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1120-1122

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

BMJ Open. 2021 Feb 22;11(2):e047216
pubmed: 33619203
Int J Obes (Lond). 2012 Aug;36(8):1072-7
pubmed: 22024641
N Engl J Med. 2021 Jul 1;385(1):90-92
pubmed: 33852796
Nat Med. 2021 Jun;27(6):981-984
pubmed: 33795870
PLoS One. 2021 Mar 24;16(3):e0245424
pubmed: 33760825
N Engl J Med. 2021 Apr 8;384(14):1372-1374
pubmed: 33691060
Clin Exp Immunol. 1982 Feb;47(2):467-73
pubmed: 7042142
Nat Commun. 2021 Jan 4;12(1):63
pubmed: 33397909
Front Immunol. 2021 Mar 12;12:657711
pubmed: 33777055
Lancet. 2021 Mar 20;397(10279):1057-1058
pubmed: 33640038
Cell Mol Immunol. 2021 Feb;18(2):318-327
pubmed: 33408342
Clin Microbiol Infect. 2020 Oct;26(10):1413.e9-1413.e13
pubmed: 32569835
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
Ann Am Thorac Soc. 2017 Nov;14(Supplement_5):S406-S409
pubmed: 29161078

Auteurs

Andrea Lombardi (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. Electronic address: andrea.lombardi@unimi.it.

Dario Consonni (D)

Epidemiology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Massimo Oggioni (M)

Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore, Milan, Italy.

Patrizia Bono (P)

Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore, Milan, Italy.

Sara Uceda Renteria (S)

Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore, Milan, Italy.

Alessandra Piatti (A)

Medical Direction, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Angela C Pesatori (AC)

Epidemiology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Clinical Sciences and Community Health, University of Milano, Milan, Italy.

Silvana Castaldi (S)

Department Biomedical Sciences for Health, University of Milan, Milan, Italy; Quality and Internal Audit Privacy Unit, University of Milan, Milan, Italy.

Antonio Muscatello (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Luciano Riboldi (L)

Occupational Health Unit, Foundation IRCCS Ca' Granda Ospedale MaggiorePoliclinico, Milan, Italy.

Ferruccio Ceriotti (F)

Clinical Laboratory, Foundation IRCCS Ca' Granda Ospedale Maggiore, Milan, Italy.

Alessandra Bandera (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.

Andrea Gori (A)

Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH